570 top medical experts on Immunoglobulin Light-chain Amyloidosis across 26 countries and 33 U.S. states, including 501 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Immunoglobulin Light-chain Amyloidosis: A nonproliferative disorder of the plasma cell characterized by excessive production and misfolding of immunoglobulin light chains that form insoluble amyloid fibrils (see amyloid deposits) in various tissues. Clinical features include liver failure; multiple myeloma; nephrotic syndrome; restrictive cardiomyopathy, and neuropathies.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Amyloidosis (3,564), Lymphoproliferative Disorders (2,703), Plasma Cell Neoplasms (947), Paraproteinemias (1,357).
  4. Clinical Trials ClinicalTrials.gov : at least 107 including 7 Active, 53 Completed, 24 Recruiting


  

        

                    


    Computing Expert Listing ...

);